Review of HIV antiretroviral drug resistance

被引：16
作者：
Fisher, Margaret C. [1 ]
Overturf, Gary D.
Cappello, Michael
Leach, Charles T.
Weinberg, Geoffrey A.
Chadwick, Ellen G.
McGann, Kathleen
Weiner, Leonard
Englund, Junet A.
Read, Jenniter S.
Woods, Charles R.
Krilov, Leonard R.
Starke, Jcffrcy R.
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
来源：
PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2008年 / 27卷 / 08期
关键词：
HIV; drug resistance;
D O I：
10.1097/INF.0b013e3181846e2e
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：749 / 752
页数：4
相关论文
共 14 条
  • [1] Geno2pheno:: estimating phenotypic drug resistance from HIV-1 genotypes
    Beerenwinkel, N
    Däumer, M
    Oette, M
    Korn, K
    Hoffmann, D
    Kaiser, R
    Lengauer, T
    Selbig, J
    Walter, H
    [J]. NUCLEIC ACIDS RESEARCH, 2003, 31 (13) : 3850 - 3855
  • [2] Prevalence and risk factors associated with antiretroviral resistance in HIV-1-infected children
    Delaugerre, Constance
    Warszawski, Josiane
    Chaix, Marie-Laure
    Veber, Florence
    Macassa, Eugenia
    Buseyne, Florence
    Rouzioux, Christine
    Blanche, Stephane
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (09) : 1261 - 1269
  • [3] Phenotypic and genotypic resistance assays: Methodology, reliability, and interpretations
    Demeter, L
    Haubrich, R
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 : S3 - S9
  • [4] Gallant Joel E, 2005, Top HIV Med, V13, P138
  • [5] Treatment for adult HIV infection - 2006 recommendations of the International AIDS Society-USA panel
    Hammer, Scott M.
    Saag, Michael S.
    Schechter, Mauro
    Montaner, Julio S. G.
    Schooley, Robert T.
    Jacobsen, Donna M.
    Thompson, Melanie A.
    Carpenter, Charles C. J.
    Fischl, Margaret A.
    Gazzard, Brian G.
    Gatell, Jose M.
    Hirsch, Martin S.
    Katzenstein, David A.
    Richman, Douglas D.
    Vella, Stefano
    Yeni, Patrick G.
    Volberding, Paul A.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (07): : 827 - 843
  • [6] Kuritzkes Daniel R, 2007, Top HIV Med, V15, P150
  • [7] Web resources for HIV type 1 genotypic-resistance test interpretation
    Liu, TF
    Shafer, RW
    [J]. CLINICAL INFECTIOUS DISEASES, 2006, 42 (11) : 1608 - 1618
  • [8] Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors
    Maggiolo, F
    Ravasio, L
    Ripamonti, D
    Gregis, G
    Quinzan, G
    Arici, C
    Airoldi, M
    Suter, F
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 40 (01) : 158 - 163
  • [9] Effect of adherence to HAART on viroloaic outcome and on the selection of resistance-conferring mutations in NNRTI- or PI-Treated patients
    Maggiolo, Franco
    Airoldi, Monica
    Kleinloog, Hendrik Daniel
    Callegaro, Annapaola
    Ravasio, Veronica
    Arici, Claudio
    Bombana, Enrico
    Suter, Fredy
    [J]. HIV CLINICAL TRIALS, 2007, 8 (05): : 282 - 292
  • [10] *PAN ANT GUID AD A, 2008, GUID US ANT AG HIV 1
12